NASDAQ

Dermata Therapeutics, Inc. - Warrant (DRMAW)

197 Thanks from members

Community market perspectives and discussion for Dermata Therapeutics, Inc. - Warrant (NASDAQ: DRMAW).

No chart available for this instrument.
Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →